David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at the Gustave Roussy, shared on LinkedIn:
“Want to master the latest breakthroughs in advanced NSCLC targeted therapies ? Here’s everything you need, straight from the leading experts …”
Title: Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies
Authors: Lizza E L Hendriks, Jessica J Lin, Daniel S W Tan, Fabian Acker, Francesca R Ogliari, May-Lucie Meyer, David Planchard, Martin Reck
You can also read:
Stage III NSCLC Management 2026: Powerful Advances Transforming Multimodal Care